Dimitrov George 4

4 · LanzaTech Global, Inc. · Filed Feb 10, 2023

Form 4

Period: 2023-02-08

Vice President, Finance

Transactions

Award
Stock Options
2023-02-08+10,000→ 10,000 total
Exercise: $1.07Exp: 2030-06-26→ Common Stock (43,746 underlying)
Award
Stock Options
2023-02-08+10,000→ 10,000 total
Exercise: $9.97Exp: 2033-01-27→ Common Stock (43,746 underlying)
Award
Stock Options
2023-02-08+10,000→ 10,000 total
Exercise: $1.38Exp: 2027-09-20→ Common Stock (43,746 underlying)
Award
Stock Options
2023-02-08+10,000→ 10,000 total
Exercise: $1.64Exp: 2028-11-21→ Common Stock (43,746 underlying)
Award
Stock Options
2023-02-08+10,000→ 10,000 total
Exercise: $1.52Exp: 2025-12-28→ Common Stock (43,746 underlying)
Award
Stock Options
2023-02-08+10,000→ 10,000 total
Exercise: $3.15Exp: 2031-12-24→ Common Stock (43,746 underlying)

Footnotes (5)

[F1]Options are fully vested and exercisable.
[F2]80% of the options are vested and exercisable, 20% vests on November 21, 2023.
[F3]60% of the options are vested and exercisable, 20% vests on each of January 1, 2024 and January 1, 2025.
[F4]25% of the options vested on December 24, 2022, 1/36th vest monthly thereafter.
[F5]On February 8, 2023, AMCI Acquisition Corp. II ("AMCI") consummated a business combination (the "Business Combination") by and among AMCI, AMCI Merger Sub, Inc., a Delaware corporation ("AMCI Merger Sub") and LanzaTech NZ, Inc., a Delaware corporation ("Legacy LanzaTech"), AMCI changed its name to "LanzaTech Global, Inc." and AMCI Merger Sub merged with and into Legacy LanzaTech. As part of the Business Combination, each Legacy LanzaTech stock option was exchanged for a stock option to acquire 4.374677 shares of common stock of LanzaTech Global, Inc.

Documents

1 file